![](/img/cover-not-exists.png)
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition
Riedemann, Niels C., Habel, Maria, Ziereisen, Jana, Hermann, Marlen, Schneider, Conny, Wehling, Cyrill, Kirschfink, Michael, Kentouche, Karim, Guo, RenfengVolume:
180
Language:
english
Journal:
Clinical Immunology
DOI:
10.1016/j.clim.2017.03.012
Date:
July, 2017
File:
PDF, 798 KB
english, 2017